On-site Participation for Blueprints for Trust: Best Practices and Regulatory Pathways for Ethical AI in Healthcare

See the opening remarks. More videos to come soon to the library page. See our AI content.

About the event:

The "Blueprints for Trust: Best Practices and Regulatory Pathways for Ethical AI in Healthcare" conference aims to bring together healthcare professionals, researchers, policymakers, ethicists, and industry leaders to explore the latest breakthroughs, challenges, and prospects of Artificial Intelligence (AI) in medicine. This conference aims to foster collaboration, encourage the exchange of ideas, and facilitate networking among diverse stakeholders to stimulate innovation and ensure AI's responsible and ethical integration in the medical field. Program begins at 8:30 AM EST and ends at 4 PM EST.

You can apply to attend the conference in-person below. Please note that while there is no cost to attend on-site, attendance spaces are very limited. Prospective attendees will need to first apply on this page AND wait to get confirmation email from the DCI team before making travel plans. We will select attendees based on their previous experience in AI and healthcare policy.

Please click here to view the Conference Webpage to see the program agenda and speakers.

Alternatively, you can attend online. Register on this other page to view the webcast on Day 1.

You can also add your comments on these topics on our online discussion forums.

Outcomes:

The conference will provide ample opportunities for networking and collaboration among attendees, as well as discussions on state-of-the-art AI solutions and products and their ethical, trust, and other challenges. Deliverables from this conference will include:

Creating policy documents for public discussion to influence regulations and implementations
A panel will be held at the fall AMIA conference summarizing the outcomes of this conference.
Creation of scientific articles for submission to leading academic journals.
Press releases on outcomes of the event
Valuable discussion points for policymakers in government and medical societies.

Key Takeaways for Participants:

Participants can expect to gain an in-depth understanding of AI’s current and future landscape in healthcare. They will leave the conference armed with fresh insights, new relationships, and the ability to contribute to the national dialogue, ensuring AI's responsible and ethical deployment in healthcare. Additionally, the conference participants will generate tangible outcomes, including whitepapers and policy papers designed to inform and influence various stakeholder groups responsible for shaping healthcare in the United States today.

Co-Organized with AMIA:

This conference is being organized in collaboration with the American Medical Informatics Association (AMIA) (https://amia.org). AMIA, the leading professional association for informatics professionals, is the center of action for 5,600 informatics professionals from more than 65 countries. As the voice of the nation’s top biomedical and health informatics professionals, AMIA and its members play a leading role in assessing the effect of health innovations on health policy and advancing the field of informatics. AMIA actively supports five domains in informatics: translational bioinformatics, clinical research informatics, clinical informatics, consumer health informatics, and public health informatics.

About DCI:

The Division of Clinical Informatics (https://research.bidmc.org/dci) at Beth Israel Deaconess Medical Center (BIDMC) is a leading center for scalable informatics research and policymaking. The DCI Network (https://www.dcinetwork.org) accelerates solutions to complex healthcare problems through multi-stakeholder alliances and strategic roadmaps, focusing on harmonizing data, improving patient engagement, and building trust in AI.

Sponsorship and Contact:

For more information about the conference and to become a sponsor, please contact DCI: Yuri Quintana, Ph.D., Chief of Division of Clinical Informatics, Beth Israel Deaconess Medical Center (BIDMC) and Assistant Professor of Medicine at Harvard Medical School (yquintan@bidmc.harvard.edu) and Gyana Srivastava, Research Assistant II, BIDMC (gsrivast@bidmc.harvard.edu).

SPONSORS

Quantori